Exforge HCT is a fixed combination of amlodipine, valsartan and hydrochlorothiazide.

NORVASC is the besylate salt of amlodipine, a long-acting calcium channel blocker.

Azor provided as a tablet for oral administration, is a combination of the calcium channel blocker (CCB) amlodipine besylate and the angiotensin II receptor blocker (ARB) olmesartan medoxomil.

Lotrel is a combination of amlodipine besylate and benazepril hydrochloride.

Tekamlo is a single tablet for oral administration of aliskiren hemifumarate (an orally active, nonpeptide, potent direct renin inhibitor) and amlodipine besylate (a dihydropyridine calcium channel blocker).

Tribenzor provided as a tablet for oral administration, is a fixed combination of olmesartan medoxomil (ARB), amlodipine (CCB), and hydrochlorothiazide (thiazide diuretic).

TWYNSTA is a fixed dose combination of telmisartan and amlodipine.

Exforge is a fixed combination of amlodipine and valsartan.

Amturnide is a single tablet for oral administration of aliskiren hemifumarate (an orally active, nonpeptide, potent direct renin inhibitor), amlodipine besylate (a dihydropyridine calcium channel blocker) and HCTZ (a diuretic).

CADUET® (amlodipine besylate, atorvastatin calcium) (amlodipine besylate and atorvastatin calcium) tablets combine the long-acting calcium channel blocker amlodipine besylate with the synthetic lipid-lowering agent atorvastatin calcium.